Detection, characterization, and staging of polyneuropathy: Assessed in diabetics

Muscle and Nerve - Tập 11 Số 1 - Trang 21-32 - 1988
P. James B. Dyck1
1Peripheral Nerve Center, Mayo Clinic & Foundation, Rochester, MN 55905

Tóm tắt

Abstract

The reported prevalence of diabetic polyneuropathy varies from 5 to 80%. This unsatisfactory state may relate to evaluation of different patient groups, different minimal criteria for the diagnosis of neuropathy, and different degrees of surveillance. To made matters worse, patients with polyneuropathy tend to be equated ignoring differences in severity. To remedy this situation, four recommendations are made: (1) population‐based patients should be studied, (2) nerve conduction should be used to set minimal criteria for neuropathy because the test is objective, sensitive, and repeatable, (3) validated tests of symptoms and deficits should also be used because clinical manifestations of neuropathy cannot be accurately inferred from electrophysiologic measurements, and (4) approaches to staging severity of neuropathy should be developed and used in expressing abnormality. To this end minimal criteria for the diagnosis of diabetic polyneuropathy have been proposed, and validated tests to assess neuropathic symptoms and sensory deficits have been developed. In this report we also propose a staging approach utilizing nerve conduction and neurologic history and examination and validated tests of neuropathic symptoms and deficits.

Từ khóa


Tài liệu tham khảo

Bird TD, 1982, Linkage of Charcot‐Marie‐Tooth neuropathy to the Duffy locus on chromosome 1, Am J. Hum Genet, 34, 388

10.1111/j.1748-1716.1954.tb01167.x

Culp WJ, 1982, Abnormal Nerves and Muscles as Impulse Generators, 750

Daube JR, 1987, Diabetic Neuropathy

10.1136/jnnp.12.4.259

10.1212/WNL.11.10.876

Dyck PJ, 1975, Peripheral Neuropathy, 296

Dyck PJ, 1982, Cecil Textbook of Medicine, 2153

Dyck PJ, 1984, Peripheral Neuropathy, 1557

10.2337/diacare.10.4.432

10.1056/NEJM198602203140801

10.1093/brain/108.4.861

Dyck PJ, 1984, Peripheral Neuropathy, 760

Dyck PJ, Diabetic Neuropathy

DyckPJ KarnesJ O'BrienPC SwansonCJ: Neuropathy symptom profile in health motor neuron disease diabetic neuropathy and amyloidosis.Neurology (NY) in press.

Dyck PJ, 1984, Peripheral Neuropathy, 1103

Dyck PJ, 1982, Clinical Neurology, 1

Dyck PJ, 1983, Linkage evidence for genetic heterogeneity among kinships with hereditary motor and sensory neuropathy type I, Mayo Clin Proc, 58, 430

10.1002/ana.410080608

10.1002/ana.410040605

Gilliatt RW, 1965, Biochemical Aspects of Neurological Disorders, 117

10.1093/brain/87.2.215

10.1001/archneurpsyc.1948.02310040011002

10.1016/S0140-6736(78)92644-2

Kimura J, 1984, Peripheral Neuropathy, 919

Lambert EH, 1956, Clinical Examination in Neurology, 287

10.1136/jnnp.33.4.442

10.1001/archneur.1962.04210040117015

Low PA, Diabetic Neuropathy

10.1016/0304-3959(75)90044-5

10.1097/00132985-196104000-00001

Palumbo PJ, 1976, Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota 1945–1970, Diabetes, 25, 566, 10.2337/diab.25.7.566

10.2337/diab.14.1.1

Rasminsky M, 1984, Peripheral Neuropathy, 911

10.2337/diab.10.1.46

Spencer PS, 1980, Experimental and Clinical Neurotoxicology, 929

Thomas PK, 1984, Peripheral Neuropathy, 1773

Windebank AJ, 1987, Diabetic Neuropathy